Artelo Biosciences (ARTL) Total Debt (2015 - 2025)

Artelo Biosciences (ARTL) has reported Total Debt for 10 consecutive years, with $437000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Total Debt changed N/A year-over-year to $437000.0 in Q4 2025; TTM through Dec 2025 was $437000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $437000.0, changed N/A from the prior year.
• Total Debt was $437000.0 for Q4 2025 at Artelo Biosciences, down from $875000.0 in the prior quarter.
• Over five years, Total Debt peaked at $875000.0 in Q3 2025 and troughed at $5000.0 in Q1 2021.
• A 4-year average of $149727.3 and a median of $43000.0 in 2022 frame the typical range for Total Debt.
• The widest YoY moves for Total Debt: up 228.95% in 2021, down 61.01% in 2021.
• Over 4 years, Total Debt stood at $38000.0 in 2021, then jumped by 39.47% to $53000.0 in 2022, then jumped by 64.15% to $87000.0 in 2023, then surged by 402.3% to $437000.0 in 2025.
• The last three Total Debt figures came in at $437000.0 (Q4 2025), $875000.0 (Q3 2025), and $87000.0 (Q1 2023), per Business Quant data.